BR0108562B1 - composiÇÕes endoparasiticidas e seu processo de preparaÇço. - Google Patents

composiÇÕes endoparasiticidas e seu processo de preparaÇço.

Info

Publication number
BR0108562B1
BR0108562B1 BRPI0108562-0A BR0108562A BR0108562B1 BR 0108562 B1 BR0108562 B1 BR 0108562B1 BR 0108562 A BR0108562 A BR 0108562A BR 0108562 B1 BR0108562 B1 BR 0108562B1
Authority
BR
Brazil
Prior art keywords
preparation process
endoparasiticidal compositions
endoparasiticidal
compositions
preparation
Prior art date
Application number
BRPI0108562-0A
Other languages
English (en)
Portuguese (pt)
Other versions
BR0108562A (pt
Inventor
Jochen Kalbe
Michael Traeubel
Georg Von Samson-Himmelst Jerna
Achim Harder
Michael Stegemann
Norbert Mencke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0108562A publication Critical patent/BR0108562A/pt
Publication of BR0108562B1 publication Critical patent/BR0108562B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BRPI0108562-0A 2000-02-22 2001-02-09 composiÇÕes endoparasiticidas e seu processo de preparaÇço. BR0108562B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Publications (2)

Publication Number Publication Date
BR0108562A BR0108562A (pt) 2002-11-12
BR0108562B1 true BR0108562B1 (pt) 2013-03-05

Family

ID=7631886

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0108562-0A BR0108562B1 (pt) 2000-02-22 2001-02-09 composiÇÕes endoparasiticidas e seu processo de preparaÇço.

Country Status (25)

Country Link
US (1) US20030125244A1 (cg-RX-API-DMAC7.html)
EP (1) EP1259250B1 (cg-RX-API-DMAC7.html)
JP (2) JP5596249B2 (cg-RX-API-DMAC7.html)
KR (1) KR100755414B1 (cg-RX-API-DMAC7.html)
CN (1) CN1309415C (cg-RX-API-DMAC7.html)
AR (2) AR028218A1 (cg-RX-API-DMAC7.html)
AT (1) ATE343394T1 (cg-RX-API-DMAC7.html)
AU (2) AU4060501A (cg-RX-API-DMAC7.html)
BR (1) BR0108562B1 (cg-RX-API-DMAC7.html)
CA (1) CA2400610C (cg-RX-API-DMAC7.html)
CZ (1) CZ300242B6 (cg-RX-API-DMAC7.html)
DE (2) DE10008128A1 (cg-RX-API-DMAC7.html)
DK (1) DK1259250T3 (cg-RX-API-DMAC7.html)
ES (1) ES2274871T3 (cg-RX-API-DMAC7.html)
HK (1) HK1054326B (cg-RX-API-DMAC7.html)
HU (1) HUP0204554A3 (cg-RX-API-DMAC7.html)
IL (2) IL150988A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02008210A (cg-RX-API-DMAC7.html)
NO (1) NO328949B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ520856A (cg-RX-API-DMAC7.html)
PL (1) PL203999B1 (cg-RX-API-DMAC7.html)
PT (1) PT1259250E (cg-RX-API-DMAC7.html)
RU (1) RU2292905C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001062268A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200205982B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
DE60230686D1 (de) * 2002-11-12 2009-02-12 Kitasato Inst Anthelmintische substanz fki-1033 und verfahren zur herstellung davon
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
AP2728A (en) 2008-08-28 2013-08-31 Pfizer Dioxa-bicyclo[3.2.1.] octane-2,3,4-triol derivatives
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
DK3298027T3 (da) 2015-05-20 2021-08-09 Boehringer Ingelheim Animal Health Usa Inc Anthelmintiske depsipeptidforbindelser
CA3009867C (en) 2015-12-28 2022-05-31 Merial, Inc. Anthelmintic cyclic depsipeptide compounds
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP4013388A1 (en) 2019-08-14 2022-06-22 Vetoquinol SA Compositions comprising tigolaner for controlling parasites

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
WO1993019053A1 (en) * 1992-03-17 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ATE295167T1 (de) * 1998-03-19 2005-05-15 Merck & Co Inc Schwefelpentafluorophenylpyrazole zur kontrolle von ektoparasitenbefall
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
RU2002125493A (ru) 2004-03-20
IL150988A0 (en) 2003-02-12
CA2400610C (en) 2013-01-22
BR0108562A (pt) 2002-11-12
AU2001240605B2 (en) 2005-04-21
MXPA02008210A (es) 2003-01-28
WO2001062268A1 (de) 2001-08-30
CA2400610A1 (en) 2001-08-30
NZ520856A (en) 2005-04-29
CZ300242B6 (cs) 2009-03-25
JP2003523397A (ja) 2003-08-05
NO20023976D0 (no) 2002-08-21
HK1054326B (zh) 2007-11-09
AR028218A1 (es) 2003-04-30
CN1309415C (zh) 2007-04-11
ES2274871T3 (es) 2007-06-01
HK1054326A1 (en) 2003-11-28
PL357551A1 (en) 2004-07-26
EP1259250B1 (de) 2006-10-25
CN1404397A (zh) 2003-03-19
KR20020072577A (ko) 2002-09-16
PT1259250E (pt) 2007-01-31
KR100755414B1 (ko) 2007-09-04
ATE343394T1 (de) 2006-11-15
PL203999B1 (pl) 2009-11-30
HUP0204554A2 (en) 2003-05-28
NO20023976L (no) 2002-10-21
HUP0204554A3 (en) 2005-05-30
US20030125244A1 (en) 2003-07-03
AU4060501A (en) 2001-09-03
DK1259250T3 (da) 2007-02-26
JP2012107024A (ja) 2012-06-07
DE50111315D1 (de) 2006-12-07
JP5596249B2 (ja) 2014-09-24
CZ20022867A3 (cs) 2003-01-15
NO328949B1 (no) 2010-06-28
AR085989A2 (es) 2013-11-13
IL150988A (en) 2011-06-30
DE10008128A1 (de) 2001-08-23
ZA200205982B (en) 2003-07-28
EP1259250A1 (de) 2002-11-27
RU2292905C2 (ru) 2007-02-10

Similar Documents

Publication Publication Date Title
DE60139185D1 (de) Vernetzbare perfluoroelastomarzusammensetzung
ATE300177T1 (de) Pestizide zusammensetzung
NL1017075A1 (nl) Preparaat.
DE60142810D1 (de) Abführende Zusammensetzungen
DE60115683D1 (de) Biostabile kleine zuleitung
DK1093146T3 (da) Sikring
DE60122878D1 (de) Sicherungseinsatz
ATE303787T1 (de) Schergelzusammensetzungen
DE50104135D1 (de) Wässrige zusammensetzungen
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
AR028197A1 (es) Composiciones antitranspirantes
BR0008181B1 (pt) processo de preparaÇço de cloro.
EP1284104A4 (en) PASTEURIZER
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60103683D1 (de) Wässrige Pestizidzusammensetzung
BR0108562B1 (pt) composiÇÕes endoparasiticidas e seu processo de preparaÇço.
DZ3424A1 (fr) Composition pesticide
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
BR0113783B1 (pt) Composição aquosa
DE60037934D1 (de) Mauerzerbrechender Gefechtskopf
BR0110478B1 (pt) composiÇço aquosa de xampu.
FR2813026B1 (fr) Broyeur de copeaux
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
ATA5832000A (de) Strumpfhose
PT1267621E (pt) Composicoes e metodos herbicidas sinergeticos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/03/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 05/03/2023